DiviDrip · DERM

DERM — Journey Medical Corporation

DERM is Journey Medical Corporation (Healthcare) — a non-dividend-paying stock. Trading at $7.77. Market cap: $214M. Capital Quality Rank: 40/100 — Stagnant mediocrity.

Stock snapshot

Price$7.77
Market cap$214M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)40 / 100 · Stagnant mediocrity
ROIC (TTM)-21.0%
Revenue CAGR (3y)-6.0%
Shareholder buyback yield-16.60%
Altman Z-score zoneDistress

About DERM

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Listed2021Employees58HQScottsdale, AZSectorHealthcareWebsitejmcderm.com

Related non-dividend companies

Other non-dividend stocks investors research alongside DERM. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is DERM's current stock price?

DERM (Journey Medical Corporation) is currently trading at $7.77.

Does DERM pay a dividend?

DERM (Journey Medical Corporation) does not currently pay a regular dividend.

What is DERM's Capital Quality Rank?

DERM has a Capital Quality Rank of 40/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track DERM in DiviDrip

Add DERM to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow